Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 101

1.

Impulse Control Disorders in Parkinson's Disease.

Weintraub D, Mamikonyan E.

Am J Psychiatry. 2019 Jan 1;176(1):5-11. doi: 10.1176/appi.ajp.2018.18040465. No abstract available.

PMID:
30848949
2.

Impulse control disorders in Chinese Parkinson's disease patients: the effect of ergot derived dopamine agonist.

Auyeung M, Tsoi TH, Tang WK, Cheung CM, Lee CN, Li R, Yeung E.

Parkinsonism Relat Disord. 2011 Sep;17(8):635-7. doi: 10.1016/j.parkreldis.2011.06.001. Epub 2011 Jun 25.

PMID:
21705258
3.

Impulse Control and Related Disorders in Parkinson's Disease.

Weintraub D, Claassen DO.

Int Rev Neurobiol. 2017;133:679-717. doi: 10.1016/bs.irn.2017.04.006. Epub 2017 Jun 1. Review.

PMID:
28802938
4.

Effects of dopamine agonist dose and gender on the prognosis of impulse control disorders in Parkinson's disease.

Joutsa J, Martikainen K, Vahlberg T, Kaasinen V.

Parkinsonism Relat Disord. 2012 Dec;18(10):1079-83. doi: 10.1016/j.parkreldis.2012.06.005. Epub 2012 Jul 10.

PMID:
22784693
5.

Developments in impulse control behaviours of Parkinson's disease.

Zurowski M, O'Brien JD.

Curr Opin Neurol. 2015 Aug;28(4):387-92. doi: 10.1097/WCO.0000000000000209. Review.

PMID:
26110803
6.

Impulse control disorders and dopamine dysregulation syndrome associated with dopamine agonist therapy in Parkinson's disease.

Fenu S, Wardas J, Morelli M.

Behav Pharmacol. 2009 Sep;20(5-6):363-79. doi: 10.1097/FBP.0b013e32833109a0. Review.

PMID:
19724195
7.

[¹¹C]-(+)-PHNO PET imaging of dopamine D(2/3) receptors in Parkinson's disease with impulse control disorders.

Payer DE, Guttman M, Kish SJ, Tong J, Strafella A, Zack M, Adams JR, Rusjan P, Houle S, Furukawa Y, Wilson AA, Boileau I.

Mov Disord. 2015 Feb;30(2):160-6. doi: 10.1002/mds.26135. Epub 2015 Jan 14.

PMID:
25641350
8.

A systematic review of impulse control disorders in Parkinson's disease.

Callesen MB, Scheel-Krüger J, Kringelbach ML, Møller A.

J Parkinsons Dis. 2013;3(2):105-38. doi: 10.3233/JPD-120165. Review.

PMID:
23938342
9.
10.

A Pilot Prospective, Multicenter Observational Study of Dopamine Agonist Withdrawal Syndrome in Parkinson's Disease.

Chaudhuri KR, Todorova A, Nirenberg MJ, Parry M, Martin A, Martinez-Martin P, Rizos A, Henriksen T, Jost W, Storch A, Ebersbach G, Reichmann H, Odin P, Antonini A.

Mov Disord Clin Pract. 2015 Mar 16;2(2):170-174. doi: 10.1002/mdc3.12141. eCollection 2015 Jun.

11.

Dopamine agonists and risk: impulse control disorders in Parkinson's disease.

Voon V, Gao J, Brezing C, Symmonds M, Ekanayake V, Fernandez H, Dolan RJ, Hallett M.

Brain. 2011 May;134(Pt 5):1438-46. doi: 10.1093/brain/awr080.

12.

Management of impulse control disorders in Parkinson's disease: Controversies and future approaches.

Samuel M, Rodriguez-Oroz M, Antonini A, Brotchie JM, Ray Chaudhuri K, Brown RG, Galpern WR, Nirenberg MJ, Okun MS, Lang AE.

Mov Disord. 2015 Feb;30(2):150-9. doi: 10.1002/mds.26099. Epub 2015 Jan 21. Review.

13.

Drug-induced impulse control disorders in Parkinson's disease.

Reiff J, Jost WH.

J Neurol. 2011 May;258(Suppl 2):S323-7. doi: 10.1007/s00415-011-5932-1. Review.

PMID:
21560063
14.

Past smoking and current dopamine agonist use show an independent and dose-dependent association with impulse control disorders in Parkinson's disease.

Valença GT, Glass PG, Negreiros NN, Duarte MB, Ventura LM, Mueller M, Oliveira-Filho J.

Parkinsonism Relat Disord. 2013 Jul;19(7):698-700. doi: 10.1016/j.parkreldis.2013.03.004. Epub 2013 Apr 20.

PMID:
23611687
15.

Diagnosis and treatment of impulse control disorders in patients with movement disorders.

Mestre TA, Strafella AP, Thomsen T, Voon V, Miyasaki J.

Ther Adv Neurol Disord. 2013 May;6(3):175-88. doi: 10.1177/1756285613476127.

16.

Impulse control disorders in advanced Parkinson's disease with dyskinesia: The ALTHEA study.

Biundo R, Weis L, Abbruzzese G, Calandra-Buonaura G, Cortelli P, Jori MC, Lopiano L, Marconi R, Matinella A, Morgante F, Nicoletti A, Tamburini T, Tinazzi M, Zappia M, Vorovenci RJ, Antonini A.

Mov Disord. 2017 Nov;32(11):1557-1565. doi: 10.1002/mds.27181. Epub 2017 Sep 27.

PMID:
28960475
17.

Association between REM sleep behaviour disorder and impulse control disorder in patients with Parkinson's disease.

Bellosta Diago E, Lopez Del Val LJ, Santos Lasaosa S, López Garcia E, Viloria Alebesque A.

Neurologia. 2017 Oct;32(8):494-499. doi: 10.1016/j.nrl.2016.02.008. Epub 2016 Apr 14. English, Spanish.

18.

Dopamine agonist withdrawal syndrome: implications for patient care.

Nirenberg MJ.

Drugs Aging. 2013 Aug;30(8):587-92. doi: 10.1007/s40266-013-0090-z. Review.

PMID:
23686524
19.

Impulse control disorders and levodopa-induced dyskinesias in Parkinson's disease: an update.

Voon V, Napier TC, Frank MJ, Sgambato-Faure V, Grace AA, Rodriguez-Oroz M, Obeso J, Bezard E, Fernagut PO.

Lancet Neurol. 2017 Mar;16(3):238-250. doi: 10.1016/S1474-4422(17)30004-2. Epub 2017 Feb 15. Review.

PMID:
28229895
20.

Parkinson's disease-related disorders in the impulsive-compulsive spectrum.

Wolters ECh, van der Werf YD, van den Heuvel OA.

J Neurol. 2008 Sep;255 Suppl 5:48-56. doi: 10.1007/s00415-008-5010-5. Review.

PMID:
18787882

Supplemental Content

Support Center